Billionaire firm NantHealth to become IPO with Allscripts investment

By Admin
Allscripts Healthcare Solutions, Inc. disclosed today (Tuesday, June 30) that it would pay $200 million for a 10 percent stake in Dr. Patrick Soon-Shion...

Allscripts Healthcare Solutions, Inc. disclosed today (Tuesday, June 30) that it would pay $200 million for a 10 percent stake in Dr. Patrick Soon-Shiong’s NantHealth firm—valuing it at $2 billion.

According to an article by the LA Times, Soon-Shiong plans to offer shares in his health care company to the public by the end of the year due to the investment.

RELATED TOPIC: Health care M&A activity continues to soar in 2015

Soon-Shiong is also investing $100 million of his personal funds in Allscripts as the financial investments strengthen the partnership between the two companies.

“For the first time, we’ve crossed the chasm from the anatomy of the human being, to the physiology of the human being to the molecular profile of the human being,” Soon-Shiong told the news source. “And we can relate that all to the treatment and the outcome.”

RELATED TOPIC: 4 reasons to take your medical records to the cloud

The two companies are expected to combine diverse medical records and genetic information “to seek personalized patient treatment.”

According to Soon-Shiong, the partnership is a key step in getting NantHealth ready to go public and predicts the public offering will happen sometime this year.

“Our joint efforts will help Allscripts lead the way in our vision of delivering … precision-based medical solutions to physicians and patients,” said Paul M. Black, president and chief executive of Allscripts.

RELATED TOPIC: Why you should invest in the medical device and mHealth market

NantHealth is converging biomolecular medicine and bioinformatics with technology services to empower physicians, payers, pharma and researchers. The company is advancing diagnostics to better identify and target specific disease characteristics.

With over 180,000 physicians as clients, Allscripts offers a full suite of population health solutions and delivers the portfolio flexibility to work with all major EHR applications in the current market.

Let's connect!   

Read the latest edition of Healthcare Global magazine!

[SOURCE: LA Times]

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare